We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IZEA:NASDAQIZEA Worldwide, Inc. Analysis

Data as of 2026-04-11 - not real-time

$3.91

Latest Price

8/10Risk

Risk Level: High

Executive Summary

IZ​EA Worldwide (IZEA) has just reported a profit turnaround, posting break‑even net income for 2025 after a $18.9 million swing, and it now sits on $50.9 million of cash to fund M&A and technology upgrades. The technical picture is mixed: the MACD histogram is positive (bullish signal) and the 20‑day SMA (3.62) sits just above the 50‑day SMA (3.58), while the 30‑day RSI at 59 indicates the stock is neither overbought nor oversold. However, the price of $3.91 is about 21 % above the DCF‑derived fair value of $3.22 and the 30‑day volatility is a lofty 61 %, suggesting heightened short‑term risk.
Fundamentally, revenue has contracted sharply (‑44.9 % YoY) and margins remain weak, with operating margin at –26.6 % and a negative forward PE of –9.5×. Nonetheless, the balance sheet is strong—debt is negligible and cash exceeds $50 million—while operating cash flow is positive. The stock carries no dividend and its beta of roughly 0.5 points to lower market‑wide sensitivity, but the high volatility and recent volume decline temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • High 30‑day volatility (61 %)
  • Bullish MACD but price above DCF fair value
  • Recent profit turnaround may need time to translate into price

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong cash position enabling strategic M&A
  • Break‑even earnings and positive operating cash flow
  • Improving profitability metrics despite revenue decline

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Persistent revenue contraction and thin margins
  • Low debt and modest book value offering downside protection
  • Sector dynamics in influencer marketing remain competitive

Key Metrics & Analysis

Financial Health

Revenue Growth-44.90%
Profit Margin0.14%
P/E Ratio-9.5
ROE0.09%
ROA-1.94%
Debt/Equity0.02
P/B Ratio1.4
Op. Cash Flow$2.4M
Free Cash Flow$364.5K
Industry P/E18.4

Technical Analysis

TrendNeutral
RSI59.7
Support$3.36
Resistance$3.99
MA 20$3.62
MA 50$3.58
MA 200$4.05
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$3.22
Target Price$7.50
Upside/Downside91.82%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.52
Volatility61.11%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.